Cart
sales@molnova.com
APY0201
CAS No. 1232221-74-7
APY0201 ( APY0201; APY-0201; APY 0201 )
Catalog No. M10917 CAS No. 1232221-74-7
APY0201 is a potent, highly selective, ATP-competitive PIKfyve inhibitor (IC50=5.2 nM) that interrupts the conversion of phosphatidylinositol 3-phosphate (PtdIns3P) to PtdIns(3,5)P2.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 64 | In Stock |
|
| 5MG | 98 | In Stock |
|
| 10MG | 173 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 530 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAPY0201
-
NoteResearch use only, not for human use.
-
Brief DescriptionAPY0201 is a potent, highly selective, ATP-competitive PIKfyve inhibitor (IC50=5.2 nM) that interrupts the conversion of phosphatidylinositol 3-phosphate (PtdIns3P) to PtdIns(3,5)P2.
-
DescriptionAPY0201 is a potent, highly selective, ATP-competitive PIKfyve inhibitor (IC50=5.2 nM) that interrupts the conversion of phosphatidylinositol 3-phosphate (PtdIns3P) to PtdIns(3,5)P2; a unique small molecular IL-12/23 production inhibitor.
-
SynonymsAPY0201; APY-0201; APY 0201
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPIKfyve
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1232221-74-7
-
Formula Weight413.48
-
Molecular FormulaC23H23N7O
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCC1=CC(/C=N/NC2=NC3=CC(C4=CC=NC=C4)=NN3C(N5CCOCC5)=C2)=CC=C1
-
Chemical Name(E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hayakawa N, et al. Bioorg Med Chem. 2014 Jun 1;22(11):3021-9.
molnova catalog
related products
-
GSK-2636771
GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
-
iMDK
iMDK quarterhydrate is a potent PI3K inhibitor that inhibits the growth factor MDK (also known as midkine or MK). iMDK quarterhydrate synergistically inhibits non-small cell lung cancer (NSCLC) with MEK inhibitors without harming normal cells and mice.
-
Splitomicin
Splitomicin (IC50 of 60 μM), a specific inhibitor of NAD(+)-dependent histone deacetylase Sir2p, displays a high activity in a cell-based assay.
